Publicaciones en las que colabora con Cristina Almenglo Buzón (7)

2024

  1. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

2022

  1. Minimal invasive fluorescence methods to quantify advanced glycation end products (AGEs) in skin and plasma of humans

    Methods, Vol. 203, pp. 103-107

  2. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis

    Scientific Reports, Vol. 11, Núm. 1

  2. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  3. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753

2020

  1. Edoxaban's contribution to key endothelial cell functions

    Biochemical Pharmacology, Vol. 178